Before prescribing ONTRUZANT, please read the accompanying
Prescribing Information, including the Boxed Warning about cardiomyopathy,
infusion reactions (pulmonary toxicity), and embryo-fetal toxicity.
CAN HELP ANSWER QUESTIONS ABOUT:
- Benefit investigations
- Billing and coding
- Co-pay assistance for eligible patients
- Prior authorizations and appeals
- Referral to the Organon Patient Assistance Program for eligibility determination (provided through the Organon Patient Assistance Program Inc.)
- Product distribution
